Pure Us Cann ETF · CUSIP 00768Y453 · who reports it, how much, and how much it matters to them
14 of the 720 hedge fund managers we track reported shares of Advisorshares TR (MSOS) on Form 13F for 30 June 2026. Between them they reported USD 136m. The largest position belongs to Anson Funds Management, at USD 62m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Anson Funds Management8 funds on PPLI.com | USD 62m | 3.7% |
| 2 | Suvretta Capital Management4 funds on PPLI.com | USD 49m | 0.9% |
| 3 | Citadel Advisors32 funds on PPLI.com | USD 7.6m | 0.0% |
| 4 | Intrinsic Edge Capital Management4 funds on PPLI.com | USD 4.1m | 0.4% |
| 5 | Elequin Capital2 funds on PPLI.com | USD 4m | 0.1% |
| 6 | Kazazian Asset Management1 fund on PPLI.com | USD 2.7m | 2.4% |
| 7 | Boothbay Fund Management2 funds on PPLI.com | USD 1.7m | 0.0% |
| 8 | Lighthouse Investment Partners190 funds on PPLI.com | USD 1.2m | 0.0% |
| 9 | Renaissance Technologies13 funds on PPLI.com | USD 849,000 | 0.0% |
| 10 | Sender Company & Partners1 fund on PPLI.com | USD 823,000 | 0.2% |
| 11 | JW Asset Management5 funds on PPLI.com | USD 787,000 | 0.2% |
| 12 | Manatuck Hill Partners6 funds on PPLI.com | USD 461,000 | 0.2% |
| 13 | Black Maple Capital Management2 funds on PPLI.com | USD 330,000 | 0.2% |
| 14 | Wexford Capital8 funds on PPLI.com | USD 292,000 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Anson Funds Management | USD 62m | 3.7% |
| 2 | Kazazian Asset Management | USD 2.7m | 2.4% |
| 3 | Suvretta Capital Management | USD 49m | 0.9% |
| 4 | Intrinsic Edge Capital Management | USD 4.1m | 0.4% |
| 5 | JW Asset Management | USD 787,000 | 0.2% |
| 6 | Sender Company & Partners | USD 823,000 | 0.2% |
| 7 | Black Maple Capital Management | USD 330,000 | 0.2% |
| 8 | Manatuck Hill Partners | USD 461,000 | 0.2% |
| 9 | Elequin Capital | USD 4m | 0.1% |
| 10 | Wexford Capital | USD 292,000 | 0.0% |
Advisorshares TR trades under the symbol MSOS. Its CUSIP, the code used on Form 13F, is 00768Y453.
14 of the 720 hedge fund managers PPLI.com tracks reported Advisorshares TR shares on Form 13F for 30 June 2026. The largest reported positions were held by Anson Funds Management (USD 62m), Suvretta Capital Management (USD 49m), Citadel Advisors (USD 7.6m), Intrinsic Edge Capital Management (USD 4.1m) and Elequin Capital (USD 4m).
14 managers in our coverage reported it, and between them they run 278 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Anson Funds Management, where the position was 3.7% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Advisorshares TR or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.